Evidence map›Paper›PMID 42359341›Full record

ArticleFrontiers in aging2026

Case Report: Exceptional longevity in turner syndrome.

Mateus Vidigal de Castro, João Paulo Limongi França Guilherme, Mayana Zatz

Abstract readCase Reports
In one paragraph

Article in Frontiers in aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mateus Vidigal de Castro *Human Genome and Stem Cell Research Center, University of São Paulo, São Paulo, SP, Brazil.
João Paulo Limongi França Guilherme *Human Genome and Stem Cell Research Center, University of São Paulo, São Paulo, SP, Brazil.
Mayana ZatzHuman Genome and Stem Cell Research Center, University of São Paulo, São Paulo, SP, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Turner Syndrome (TS), caused by complete or partial monosomy of chromosome X, is associated with increased morbidity and reduced life expectancy, largely driven by cardiovascular, endocrine, and metabolic complications. Here, we report the case of a 75-year-old woman with a confirmed diagnosis of non-mosaic TS (45,X) who remains clinically stable and functionally independent, beyond the expected survival for this condition. Notably, her mother is currently 101 years old, indicating a familial background of exceptional longevity. To explore the potential contribution of inherited genetic factors to this favorable phenotype, whole-genome sequencing (WGS) was performed in both the TS patient and her centenarian mother aiming to identify variants potentially associated with healthy aging and longevity. Hematological and biochemical analyses were subsequently used to functionally support the genetic and clinical findings, revealing preserved metabolic, inflammatory, and hematological profiles for the patient age. Together, these data suggest that a favorable genetic background may partially counterbalance the risks traditionally associated with X chromosome monosomy, contributing to preserved functional status into older age.

Indexed as

aginggenetic variantshealthlongevityresilienceturner syndrome

Identifiers

PMID42359341
PMCPMC13291543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.